CN4 COST-EFFECTIVENESS OF ANASTROZOLE VS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (EBC)- A UK NATIONAL HEALTH SERVICE (NHS) PERSPECTIVE
May 1, 2004, 00:00
10.1016/S1098-3015(10)62069-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)62069-4/fulltext
Title :
CN4 COST-EFFECTIVENESS OF ANASTROZOLE VS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER (EBC)- A UK NATIONAL HEALTH SERVICE (NHS) PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62069-4&doi=10.1016/S1098-3015(10)62069-4
First page :
Section Title :
Open access? :
No
Section Order :
7